Prostate cancer Board decisions

The Veteran's prostate cancer residuals were not productive of a daytime voiding interval of less than one hour or awakening to void five or more times per night, nor did they require use of an appliance. From April 29, 2013, the residuals have required the wearing of absorbent materials which must be changed 2 to 4 times per day.

The Veteran's prostate condition, including prostatitis and prostate cancer, is presumed to be due to in-service exposure to herbicide agents. The Board finds service connection for this condition is granted.

The Veteran's prostate cancer and erectile dysfunction are service-connected, with the latter being secondary to his prostate cancer. The Veteran is also entitled to special monthly compensation for loss of use of a creative organ.

The Board has determined that the October 2014 VA examination is inadequate for adjudicating the claim and requires a remand to address the issues of causation and aggravation.

The Veteran's claims for service connection are denied as there is no evidence of herbicide exposure or a nexus to his claimed conditions.

The Board has remanded the case for additional development, including obtaining complete service personnel records and VA treatment records, verifying herbicide exposure in Thailand, and obtaining any relevant documents. The Veteran's claims will be reconsidered based on the new evidence.

The Veteran's total rating for service-connected prostate cancer was restored from February 1, 2013 to the present due to improper termination without consideration of applicable regulations.

The Veteran's bilateral hearing loss was increased to a 20% rating effective October 30, 2015. Service connection for prostate cancer due to herbicide exposure was granted.

The Board found that the Veteran's prostate cancer was not incurred or aggravated by service and is not related to military service. The claim for service connection was denied.

The Veteran's prostate cancer is presumed to have been incurred during his active service due to Agent Orange exposure, and the Board grants this claim.

The Veteran's appeal is being remanded due to the need for further verification of his exposure to herbicides in Japan, as claimed. The AOJ will follow VA procedures to verify this claim and then proceed with adjudication.

The Veteran withdrew all issues on appeal, including the reopening of a claim for coronary artery disease and service connection for prostate cancer.

The Veteran's appeal has been withdrawn by the appellant prior to a decision being made.

The Veteran's service-connected prostate cancer is found to be the principal cause of his death, and thus service connection for the cause of death is granted.

The Board found that the Veteran's heart disease and prostate cancer did not meet the criteria for service connection, as they were not shown to be related to his active duty service. The appeal was denied.

The Veteran's service-connected residuals of prostate cancer are rated at 60 percent since June 1, 2009 for voiding dysfunction. A separate 10 percent rating is granted for frequent loose stools.

The Board has granted service connection for prostate cancer, finding that the Veteran was exposed to herbicides in Thailand and is entitled to presumptive service connection based on this exposure.

The Board found no evidence of herbicide exposure and denied the Veteran's claim for service connection for prostate cancer, as it is not related to his active duty service.

The Veteran's service connection for prostate cancer residuals was granted, with a rating of 60 percent effective June 17, 2013. The claimant reported symptoms warranting this higher rating.

The Veteran's claims for service connection for prostate cancer, skin cancer, and thyroid disability are being remanded due to the need for additional development regarding his exposure to radiation in service.